Cargando…
Family-based genome-wide association of inflammation biomarkers and fenofibrate treatment response in the GOLDN study
In this paper we analyzed whole-genome genetic information provided by GAW20 from the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) study for family data. Lipid levels such as triglycerides (TGs) and high-density lipoprotein (HDL) are measured at different time points before and after ad...
Autores principales: | Das, Sarmistha, Mondal, Pronoy Kanti, Ghosh, Saurabh, Mukhopadhyay, Indranil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157183/ https://www.ncbi.nlm.nih.gov/pubmed/30275891 http://dx.doi.org/10.1186/s12919-018-0146-5 |
Ejemplares similares
-
Modification effect of fenofibrate therapy, a longitudinal epigenomic-wide methylation study of triglycerides levels in the GOLDN study
por: Wei, Runmin, et al.
Publicado: (2018) -
Lipid changes due to fenofibrate treatment are not associated with changes in DNA methylation patterns in the GOLDN study
por: Das, Mithun, et al.
Publicado: (2015) -
Integrating epigenetic, genetic, and phenotypic data to uncover gene-region associations with triglycerides in the GOLDN study
por: Romanescu, Razvan G., et al.
Publicado: (2018) -
The PPAR Alpha gene is associated with triglyceride, low-density cholesterol, and inflammation marker response to fenofibrate intervention: The GOLDN Study
por: Frazier-Wood, A.C., et al.
Publicado: (2012) -
An efficient analytic approach in genome-wide identification of methylation quantitative trait loci response to fenofibrate treatment
por: Cox, Jiayi Wu, et al.
Publicado: (2018)